Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology

被引：0

作者：

Esteban Javier Rozen

Jason Matthew Shohet

机构：

[1] UMass Chan Medical School,Department of Pediatrics

[2] Lazare Research Building LRB603,Division of Hematology/Oncology, Department of Pediatrics

[3] UMass Chan Medical School,undefined

[4] Lazare Research Building LRB603,undefined

来源：

Cancer and Metastasis Reviews | 2022年 / 41卷

关键词：

RTK; Kinase inhibitor; Neuroblastoma; RET; DDR2;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：33 / 52

页数：19

共 50 条

[21] RET receptor tyrosine kinase isoforms in kidney function and disease [J].

Lee, DCW ;

Chan, KW ;

Chan, SY .

ONCOGENE, 2002, 21 (36) :5582-5592

[22] Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK [J].

Murray, Phillip B. ;

Lax, Irit ;

Reshetnyak, Andrey ;

Ligon, Gwenda F. ;

Lillquist, Jay S. ;

Natoli, Edward J., Jr. ;

Shi, Xiarong ;

Folta-Stogniew, Ewa ;

Gunel, Murat ;

Alvarado, Diego ;

Schlessinger, Joseph .

SCIENCE SIGNALING, 2015, 8 (360)

[23] A substrate peptide for the FLT3 receptor tyrosine kinase [J].

Boehmer, Frank-D. ;

Uecker, Andrea .

BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (01) :127-130

[24] RET receptor tyrosine kinase isoforms in kidney function and disease [J].

Davy Chun Wai Lee ;

Kwok Wah Chan ;

Siu Yuen Chan .

Oncogene, 2002, 21 :5582-5592

[25] Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo [J].

Li, Haoyu ;

Wang, Yongfeng ;

Chen, Zhenghu ;

Lu, Jiaxiong ;

Pan, Jessie ;

Yu, Yang ;

Zhao, Yanling ;

Zhang, Huiyuan ;

Hu, Ting ;

Liu, Qing ;

Yang, Jianhua .

ONCOTARGET, 2017, 8 (04) :5874-5884

[26] Risk factors of neuroblastoma: a systematic review and meta-analysis [J].

Onyije, Felix M. ;

Dolatkhah, Roya ;

Olsson, Ann ;

Bouaoun, Liacine ;

Schuz, Joachim .

FRONTIERS IN PUBLIC HEALTH, 2025, 13

[27] Neuroblastoma survivors at risk for developing subsequent neoplasms: A systematic review [J].

Westerveld, Aimee S. R. ;

Dalen, Elvira C. van ;

Asogwa, Ogechukwu A. ;

Koopman, Maria M. W. ;

Papadakis, Vassilios ;

Laureys, Genevieve ;

van der Pal, Helena J. H. ;

Kremer, Leontien C. M. ;

Tytgat, Godelieve A. M. ;

Teepen, Jop C. .

CANCER TREATMENT REVIEWS, 2022, 104

[28] Autophagy and receptor tyrosine kinase signalling: A mTORC2 matter [J].

Lampada, Aikaterini ;

Hochhauser, Daniel ;

Salomoni, Paolo .

CELL CYCLE, 2017, 16 (20) :1855-1856

[29] THE XMRK RECEPTOR TYROSINE KINASE IS ACTIVATED IN XIPHOPHORUS MALIGNANT-MELANOMA [J].

WITTBRODT, J ;

LAMMERS, R ;

MALITSCHEK, B ;

ULLRICH, A ;

SCHARTL, M .

EMBO JOURNAL, 1992, 11 (11) :4239-4246

[30] A review on tyrosine kinase inhibitors for targeted breast cancer therapy [J].

Sankarapandian, Vidya ;

Rajendran, Ramya Lakshmi ;

Miruka, Conrad Ondieki ;

Sivamani, Poornima ;

Maran, Balu Alagar Venmathi ;

Krishnamoorthy, Rajapandiyan ;

Gangadaran, Prakash ;

Ahn, Byeong-Cheol .

PATHOLOGY RESEARCH AND PRACTICE, 2024, 263 :155607

← 1 2 3 4 5 →